Potential biomarkers of nonobstructive azoospermia identified in microarray gene expression analysis.

Area of Science:

• Reproductive biology and genetics
• Molecular diagnostics
• Male infertility research

Background:

• Azoospermia, the absence of sperm in ejaculate, is a major cause of male infertility.
• Identifying biomarkers for spermatogenic differentiation is crucial for diagnosing nonobstructive azoospermia (NOA).
• Current diagnostic methods for NOA lack molecular specificity regarding the stage of spermatogenic impairment.

Purpose of the Study:

• To identify novel gene expression biomarkers for azoospermia.
• To correlate gene expression patterns with specific stages of spermatogenetic differentiation in men with NOA.
• To develop a molecular diagnostic tool for assessing the degree of spermatogenic impairment.

Main Methods:

• Gene expression profiling using Affymetrix Human Gene 1.0 ST microarrays on testicular biopsy samples from men with NOA and controls.
• Validation of differentially expressed genes at mRNA and protein levels using quantitative polymerase chain reaction, Western blot, and immunohistochemistry.
• Analysis of 31 testicular biopsy samples from 18 men with NOA and 4 men with normal spermatogenesis.

Main Results:

• Identification of 4,946 differentially expressed genes between infertile and control groups.
• Significant down-regulation of genes including AKAP4, UBQLN3, and GGN in infertile patients.
• Identification of up-regulated genes such as WBSCR28 and ADCY10 in men with late maturation arrest.
• Quantitative polymerase chain reaction and Western blot largely confirmed microarray findings.

Conclusions:

• A specific set of genes shows altered expression in men with idiopathic nonobstructive azoospermia.
• These identified genes hold potential for developing a molecular diagnostic tool.
• The tool could precisely determine the degree of spermatogenic impairment in men with NOA.